TITLE:
      Alternate Day Buprenorphine Administration, Phase IX - 14
SUMMARY:
      The purpose of this study is to determine if four times a subjects' daily maintenance dose
      will hold for 120 hours without changes in agonist and antagonist effects.
ELIGIBILITY CRITERIA:
      Please contact site for information.
